NO300087B1 - Fremgangsmåte ved fremstilling av et transdermalt terapeutisk system med trinnvis virkestoffavgivelse - Google Patents
Fremgangsmåte ved fremstilling av et transdermalt terapeutisk system med trinnvis virkestoffavgivelse Download PDFInfo
- Publication number
- NO300087B1 NO300087B1 NO901128A NO901128A NO300087B1 NO 300087 B1 NO300087 B1 NO 300087B1 NO 901128 A NO901128 A NO 901128A NO 901128 A NO901128 A NO 901128A NO 300087 B1 NO300087 B1 NO 300087B1
- Authority
- NO
- Norway
- Prior art keywords
- active substance
- membrane
- reservoir
- release
- substances
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 12
- 230000001225 therapeutic effect Effects 0.000 title description 5
- 229940100640 transdermal system Drugs 0.000 claims abstract description 6
- 239000013543 active substance Substances 0.000 claims description 86
- 239000012528 membrane Substances 0.000 claims description 80
- 239000010410 layer Substances 0.000 claims description 21
- 230000035699 permeability Effects 0.000 claims description 14
- 239000000126 substance Substances 0.000 claims description 12
- -1 polyethylene Polymers 0.000 claims description 9
- 238000012423 maintenance Methods 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 229920001577 copolymer Polymers 0.000 claims description 4
- 229920001296 polysiloxane Polymers 0.000 claims description 4
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 3
- 239000005977 Ethylene Substances 0.000 claims description 3
- 239000004952 Polyamide Substances 0.000 claims description 3
- 239000004698 Polyethylene Substances 0.000 claims description 3
- 229920002647 polyamide Polymers 0.000 claims description 3
- 229920000573 polyethylene Polymers 0.000 claims description 3
- 239000011241 protective layer Substances 0.000 claims description 3
- 239000004821 Contact adhesive Substances 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 4
- 239000002537 cosmetic Substances 0.000 abstract description 2
- 230000002500 effect on skin Effects 0.000 abstract description 2
- 230000009885 systemic effect Effects 0.000 abstract description 2
- 239000011159 matrix material Substances 0.000 description 11
- 239000000853 adhesive Substances 0.000 description 10
- 239000004480 active ingredient Substances 0.000 description 9
- 239000011888 foil Substances 0.000 description 9
- 230000004907 flux Effects 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 7
- 230000001070 adhesive effect Effects 0.000 description 6
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 5
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 5
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 5
- 230000035515 penetration Effects 0.000 description 5
- 230000001681 protective effect Effects 0.000 description 5
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 5
- 229960002646 scopolamine Drugs 0.000 description 5
- 239000012790 adhesive layer Substances 0.000 description 4
- 230000001186 cumulative effect Effects 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000000470 constituent Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229940001470 psychoactive drug Drugs 0.000 description 2
- 239000004089 psychotropic agent Substances 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- NNJPGOLRFBJNIW-HNNXBMFYSA-N (-)-demecolcine Chemical compound C1=C(OC)C(=O)C=C2[C@@H](NC)CCC3=CC(OC)=C(OC)C(OC)=C3C2=C1 NNJPGOLRFBJNIW-HNNXBMFYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 239000002830 appetite depressant Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 201000003152 motion sickness Diseases 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 229940124641 pain reliever Drugs 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Medical Informatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- External Artificial Organs (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3908431A DE3908431A1 (de) | 1989-03-15 | 1989-03-15 | Transdermales system mit gestufter wirkstoffabgabe und verwendung fuer die lokale oder systemische wirkstoffverabreichung |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO901128D0 NO901128D0 (no) | 1990-03-09 |
| NO901128L NO901128L (no) | 1990-09-17 |
| NO300087B1 true NO300087B1 (no) | 1997-04-07 |
Family
ID=6376396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO901128A NO300087B1 (no) | 1989-03-15 | 1990-03-09 | Fremgangsmåte ved fremstilling av et transdermalt terapeutisk system med trinnvis virkestoffavgivelse |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0387693B1 (zh) |
| JP (1) | JPH0693921B2 (zh) |
| KR (1) | KR960005148B1 (zh) |
| AT (1) | ATE143276T1 (zh) |
| AU (1) | AU625402B2 (zh) |
| CA (1) | CA2012123C (zh) |
| CZ (1) | CZ284770B6 (zh) |
| DD (1) | DD292383A5 (zh) |
| DE (2) | DE3908431A1 (zh) |
| DK (1) | DK0387693T3 (zh) |
| ES (1) | ES2095216T3 (zh) |
| FI (1) | FI901290A0 (zh) |
| GR (1) | GR3022033T3 (zh) |
| HR (1) | HRP930662A2 (zh) |
| HU (1) | HU206991B (zh) |
| IL (1) | IL93678A (zh) |
| MY (1) | MY107420A (zh) |
| NO (1) | NO300087B1 (zh) |
| NZ (1) | NZ232895A (zh) |
| PH (1) | PH26276A (zh) |
| PL (1) | PL162693B1 (zh) |
| PT (1) | PT93430B (zh) |
| SI (1) | SI9010493B (zh) |
| SK (1) | SK279357B6 (zh) |
| YU (1) | YU48228B (zh) |
| ZA (1) | ZA901941B (zh) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4341444C2 (de) * | 1993-12-04 | 1996-03-14 | Lohmann Therapie Syst Lts | Wirkstoffhaltiges Pflaster und Verfahren zu seiner Herstellung |
| AU3512595A (en) * | 1994-09-13 | 1996-03-29 | Magainin Pharmaceuticals, Inc. | Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds |
| US5714162A (en) * | 1994-09-16 | 1998-02-03 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Scopolamine patch |
| DE4438989C2 (de) * | 1994-09-16 | 1999-02-25 | Lohmann Therapie Syst Lts | Scopolaminpflaster |
| DE19705138A1 (de) * | 1997-02-11 | 1998-08-13 | Lohmann Therapie Syst Lts | Dehnbares transdermales therapeutisches System |
| DE19733981A1 (de) * | 1997-08-06 | 1999-02-11 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System (TTS) zur Abgabe von Wirkstoff durch die Haut an einen Organismus und Verfahren zur Applikation auf der Haut |
| DE19738643C2 (de) * | 1997-09-04 | 2001-10-04 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit dem Wirkstoff Scopolaminbase und Verfahren zu seiner Herstellung |
| DE10056012A1 (de) * | 2000-11-11 | 2002-05-16 | Beiersdorf Ag | Flexible Barrierefolie für ein Trägermaterial für medizinische Zwecke |
| DE10056014A1 (de) * | 2000-11-11 | 2002-05-16 | Beiersdorf Ag | Mehrschichtige Trägerkonstruktion für wirkstofhaltige Pflastersyteme |
| DE102004020463A1 (de) * | 2004-04-26 | 2005-11-10 | Grünenthal GmbH | Wirkstoffabgabesystem aus einem wirkstoffhaltigen Pflaster und mindestens einem Wirkstoffabgaberegulierungsmittel |
| CA2832339C (en) | 2011-04-04 | 2020-03-10 | The Procter & Gamble Company | Personal care article |
| EP2744883B1 (en) | 2011-08-15 | 2018-12-26 | The Procter and Gamble Company | Personal care articles having multiple zones with compliant personal care compositions |
| US8795695B2 (en) | 2011-08-15 | 2014-08-05 | The Procter & Gamble Company | Personal care methods |
| CN105307731B (zh) | 2013-06-27 | 2019-09-24 | 宝洁公司 | 防腐性个人护理组合物 |
| DE102018216244A1 (de) | 2018-09-24 | 2020-03-26 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System mit Barriereschicht |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5755157A (en) * | 1980-09-19 | 1982-04-01 | Nitto Electric Ind Co | Drug member having transcataneous absorbing property |
| IE53703B1 (en) * | 1982-12-13 | 1989-01-18 | Elan Corp Plc | Drug delivery device |
| US4698062A (en) * | 1985-10-30 | 1987-10-06 | Alza Corporation | Medical device for pulsatile transdermal delivery of biologically active agents |
| US4666441A (en) * | 1985-12-17 | 1987-05-19 | Ciba-Geigy Corporation | Multicompartmentalized transdermal patches |
| DE3634016A1 (de) * | 1986-04-17 | 1987-10-29 | Lohmann Gmbh & Co Kg | Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung |
| ES2028074T3 (es) * | 1986-06-13 | 1992-07-01 | Alza Corporation | Activacion por humedad de un sistema de suministro transdermico de farmacos. |
| US4781924A (en) * | 1987-11-09 | 1988-11-01 | Alza Corporation | Transdermal drug delivery device |
-
1989
- 1989-03-15 DE DE3908431A patent/DE3908431A1/de active Granted
-
1990
- 1990-03-07 PH PH40155A patent/PH26276A/en unknown
- 1990-03-07 AU AU50765/90A patent/AU625402B2/en not_active Ceased
- 1990-03-07 MY MYPI90000358A patent/MY107420A/en unknown
- 1990-03-08 DE DE59010514T patent/DE59010514D1/de not_active Expired - Fee Related
- 1990-03-08 DK DK90104406.5T patent/DK0387693T3/da active
- 1990-03-08 EP EP90104406A patent/EP0387693B1/de not_active Expired - Lifetime
- 1990-03-08 AT AT90104406T patent/ATE143276T1/de not_active IP Right Cessation
- 1990-03-08 SK SK1136-90A patent/SK279357B6/sk unknown
- 1990-03-08 ES ES90104406T patent/ES2095216T3/es not_active Expired - Lifetime
- 1990-03-08 CZ CS901136A patent/CZ284770B6/cs unknown
- 1990-03-08 IL IL9367890A patent/IL93678A/en not_active IP Right Cessation
- 1990-03-09 NO NO901128A patent/NO300087B1/no not_active IP Right Cessation
- 1990-03-12 JP JP2058241A patent/JPH0693921B2/ja not_active Expired - Fee Related
- 1990-03-13 DD DD90338650A patent/DD292383A5/de unknown
- 1990-03-13 NZ NZ232895A patent/NZ232895A/xx unknown
- 1990-03-13 HU HU901422A patent/HU206991B/hu not_active IP Right Cessation
- 1990-03-14 ZA ZA901941A patent/ZA901941B/xx unknown
- 1990-03-14 SI SI9010493A patent/SI9010493B/sl unknown
- 1990-03-14 PT PT93430A patent/PT93430B/pt not_active IP Right Cessation
- 1990-03-14 YU YU49390A patent/YU48228B/sh unknown
- 1990-03-14 CA CA002012123A patent/CA2012123C/en not_active Expired - Fee Related
- 1990-03-14 KR KR1019900003563A patent/KR960005148B1/ko not_active IP Right Cessation
- 1990-03-14 PL PL28430190A patent/PL162693B1/pl unknown
- 1990-03-15 FI FI901290A patent/FI901290A0/fi not_active Application Discontinuation
-
1993
- 1993-04-01 HR HR930662A patent/HRP930662A2/hr not_active Application Discontinuation
-
1996
- 1996-12-13 GR GR960403458T patent/GR3022033T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Patel et al. | TRANSDERMAL DRUG DELIVERY SYSTEM: A REVIEW. | |
| US9616045B2 (en) | Transdermal therapeutic system having improved long-term wearing comfort | |
| KR970008118B1 (ko) | 피부 침투성 치료 시스템 | |
| CA1297369C (en) | Moisture activation of transdermal drug delivery system | |
| AU678237B2 (en) | Active substance-containing plaster | |
| JP2588039B2 (ja) | 段階的な活性物質放出を呈する皮膚経由医療薬として使用されるプラスタ及びその製造方法 | |
| NO300087B1 (no) | Fremgangsmåte ved fremstilling av et transdermalt terapeutisk system med trinnvis virkestoffavgivelse | |
| KR910002250B1 (ko) | 피부에 유효약제를 조절하여 투여하는 유효약제-함유 플래스터 | |
| JPH01135717A (ja) | 改良された薬物経皮供給デバイス | |
| JP2003515555A (ja) | 同一有効成分を含有する貯留部と基質部を備えた経皮投与部材 | |
| US5176917A (en) | Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances | |
| JP3178891B2 (ja) | 微粉体制御型経皮投与製剤 | |
| ES2355275T5 (es) | Emplasto que contiene fenantilo | |
| MXPA97005324A (en) | Transdermal therapeutic system for the supply of (s) -3-methyl-5- (1-methyl-2-pirrolidenyl) -isoxazole or any of its salts pharmaceutically ap |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN SEPTEMBER 2002 |